Verified ProfileEN

Nanjing GenScript Biotechnology Co., Ltd.

Order verification — $199

Manufacturing · Biological Product Manufacturing

Verification dossier

Nanjing GenScript Biotechnology Co., Ltd. is a Chinese company based in Nanjing, Jiangsu. The company operates in the biological product manufacturing sector, within the broader manufacturing industry. Established 2009, the company has been operating for 17 years.

Sinolinks tracks Nanjing GenScript Biotechnology Co., Ltd. as part of our independent verification practice. The full 18-section verification report covers ownership, financial standing, regulatory standing, trade relationships, and operating credentials — reviewed by our Hong Kong-based expert and delivered in 24 hours.

Business scope

Technical services, technical development, preparation, sales, and after-sales technical services related to bioengineering, biomedical engineering, and bio-agricultural engineering; production and sales of health food; self-operated and agency import/export business for various goods and technologies (excluding those restricted or prohibited by the state). Licensed items: production of Class II medical devices; production of Class III medical devices; operation of Class III medical devices. General items: sales of Class II medical devices; engineering and technical research and experimental development; sales of specialized chemical products (excluding hazardous ones).

Independent verification

Order the full verified report on this company

An 18-section verification report on this Chinese company, expert-reviewed and delivered in English within 24 hours. We support clients in six languages. HK-entity invoicing.

Order verification — $199

Independent verification

Included in the full report

Full Chinese legal name

Registration identifier

Legal representative & senior officers

Beneficial ownership & equity history

Registered address & operating premises

Capital & recent annual filings

Verified contact channels

Branches, controlled entities & investments

Trademark & patent portfolio

Trade relationships

Regulatory standing review